The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...

"Instead of travelling to clinics for injections, there is now a daily tablet ... gonadotropin-releasing hormone (GnRH) agonists, and surgery. The regulator emphasised that unlike current ...

“In contrast to currently used peptidic GnRH agonists that are administered by injection or nasal spray, elagolix is not a peptide and can therefore be orally administered, which could be prefer ...

A first-of-its-kind daily pill for endometriosis has been approved by NHS England for patients who have exhausted all other ...